Anebulo Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ANEB on Nasdaq
Industry
Pharmaceutical Preparations
Location
Jfl Capital Management, 1017 Rr 620 S, Suite 107, Lakeway, TX

There are no Buy or Sell transactions made by insiders since 12/24/2023

Anebulo Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aron R. English Director, 10%+ Owner $28.2M Jun 13, 2024
Kenneth C. Cundy Chief Scientific Officer Feb 29, 2024
Jason Aryeh Director Jun 13, 2024
Richard Anthony Cunningham Chief Executive Officer, Director Dec 9, 2024
Simon Allen Chief Executive Officer, Director Dec 9, 2022
Joseph F. Lawler Director Jun 13, 2024
Kenneth Lin Director Jun 13, 2024
Bimal R. Shah Director Jun 13, 2024
Karah Herdman Parschauer Director Apr 21, 2022
Sandra A. Gardiner Acting Chief Financial Officer Mar 2, 2023
Areta Kupchyk Director Jun 13, 2024
Nathaniel Calloway Director Jun 13, 2024
Dan George Chief Financial Officer Sep 28, 2023

Recent Insider Transactions by Companies or Individuals for Anebulo Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.